Daylife Select
A point & click tool to create dynamic content portals. Learn More »
Editor's Picks
There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
-
04 December 2009 AMMAN - Jordan and Egypt have decided to remove restrictions related to the import of medicines manufactured in both countries to facilitate trade, a Jordanian official said on Thursday. Full Article at Zawya.com
-
LONDON -- Drugmaker AstraZeneca said Friday that the U.S. Food and Drug Administration has approved its once-daily Seroquel XR extended release tablets as adjunctive (add-on) treatment to antidepressants in adults with major depressive disorder. Full Article at FOX News
-
LONDON (MarketWatch) -- Drugmaker AstraZeneca /quotes/comstock/23s!a:azn (UK:AZN 2,772, 0.00, 0.00%) /quotes/comstock/13*!azn/quotes/nls/azn (AZN 45.62, -0.31, -0.67%) said Friday that the U.S. Food and Drug Administration has approved its... Full Article at MarketWatch
-
The federal Food and Drug Administration, which has oversight of pet-food manufacturing, said an investigation is under way. The probe could lead to enforcement actions aimed at getting the company to correct problems, a spokesman said. Full Article at The State
-
Main Category: Smoking / Quit Smoking Also Included In: Regulatory Affairs / Drug Approvals Article Date: 03 Dec 2009 - 16:00 PST email to a friend printer friendly view / write opinions rate article When President Barack Obama signed the... Full Article at Medical News Today
-
Genzyme Corp. yesterday said it has scrapped its application to produce Lumizyme, a drug to treat the rare genetic disorder Pompe disease, in midsize bioreactors and instead will pursue a new pathway toward making the drug on a larger scale. Full Article at Boston Globe
-
“The American Cancer Society, World Health Organization, the Food and Drug Administration and the International Commission on Non-Ionizing Radiation Protection all agree: A survey of the recent scientific literature shows there is no clear evidence of... Full Article at Rational Review
-
CAMBRIDGE, Mass. -- (BUSINESS WIRE) -- InVivo Therapeutics Corporation has filed an Investigational Device Exemption application with the Food and Drug Administration requesting permission to advance to human clinical studies. Full Article at Freshnews.com
-
WASHINGTON (AP) — A consumer advocacy group is petitioning the government to ban the weight loss pill Meridia because a recent study suggests it increases risk of heart attack, stroke and death. Full Article at Chicago Tribune
-
Unilever United States, Inc. Full Article at Street Insider
-
Here are some of the latest health and medical news developments, compiled by editors of HealthDay: Inspectors found unsanitary conditions at a Tyson Foods plant in Forth Worth, Tex. , that makes seafood soups, says a U.S. Food and Drug Administration... Full Article at MedicineNet
-
WEDNESDAY, Dec. 2 (HealthDay News) -- Merck & Co.'s Zegerid OTC (omeprazole/sodium bicarbonate) has been approved by the U.S. Food and Drug Administration to treat frequent heartburn, the company said Wednesday in a news release. Full Article at MedicineNet
-
David Gardner called it. He’s up 1,334%! See what David’s recommending that you buy NEXT. You've got to love biotech. In what other industry can you routinely see double-digit single-day pops? Yesterday it was Dyax's (Nasdaq: DYAX) and Santarus' Full Article at Motley Fool
-
THURSDAY, Dec. 3 (HealthDay News) -- Kalbitor (ecallantide) has been approved by the U.S. Food and Drug Administration to treat dangerous flares of sudden fluid buildup in people with hereditary angiodema (HAE), the agency said. Full Article at ABC News
-
The Food and Drug Administration has created a partnership with Everyday Health to deliver FDA's consumer health information to the 30 million users who visit Everyday Health (www.EverydayHealth.com) each month. Full Article at Miami Herald
-
Dec. 3 (Bloomberg) -- Secret communications between drugmakers and U.S. regulators about product delays may become public record, a move one health official says would prevent his staff from wasting time on incomplete applications. Full Article at Bloomberg.com
-
The Food and Drug Administration has requested additional information from Endo Pharmaceuticals about what the company called “very rare, but serious adverse events” linked to Aveed, its experimental injectable drug it is seeking approval for as a... Full Article at Philadelphia Business Journal
-
THURSDAY, Dec. 3 (HealthDay News) -- Add colorectal cancer to the list of malignancies caused by smoking, with a new study strengthening the link between the two. Full Article at Glam.com
-
WASHINGTON (AP) — A consumer advocacy group is petitioning the government to ban the weight loss pill Meridia because a recent study suggests it increases risk of heart attack, stroke and death. Full Article at Chicago Tribune
About Food and Drug Administration
Wikipedia
The U.S. Food and Drug Administration (FDA) is an agency of the United States Department of Health and Human Services and is responsible for the safety regulation of most types of foods, dietary supplements, drugs, vaccines, biological medical products, blood products, medical devices, radiation-emitting devices, veterinary products, and cosmeti... Full Article
Related Photos
prev
next
-
Getty Images
WASHINGTON - SEPTEMBER 29: (L-R) Office of Compliance of the Food and Drug Administration's Center for Drug Evaluation and Research Division Director Michael Levy, Drug Enforcement Administration Deputy Assistant Administrator Joseph Rannazzisi, United States Anti Doping Agency CEO Tra...
View Photo » -
Getty Images
WASHINGTON - SEPTEMBER 29: Office of Compliance of the Food and Drug Administration's Center for Drug Evaluation and Research Division Director Michael Levy testifies before the Senate Judiciary Committee's Crime and Drugs Subcommittee during a hearing on 'Body Building Products and Hi...
View Photo » -
Getty Images
WASHINGTON - SEPTEMBER 29: Deputy commissioner of the Food and Drug Administration Jesse Goodman testifies before the House Oversight and Government Reform Committee September 29, 2009 in Washington, DC.
View Photo » -
AP Photo
Michael Levy, director of the Food and Drug Administration's (FDA) division of new drugs and labeling compliance, testifies on Capitol Hill in Washington, Tuesday, Sept. 29, 2009, before a Senate Judiciary subcommittee hearing on dietary supplements.
View Photo » -
AP Photo
FILE - In this May 7, 2009 file photo, Food and Drug Administration Commissioner Margaret Hamburg testifies on Capitol Hill in Washington.
View Photo » -
AP Photo
The FDA has approved ONGLYZA(TM) (saxagliptin).
View Photo » -
AP Photo
FDA Approves Constar's new DiamondClear(R) Technology for PET Containers.
View Photo » -
AP Photo
FILE - In this May 7, 2009, file photo, Food and Drug Administration Commissioner-designate Margaret Hamburg speaks at confirmation hearing on Capitol Hill in Washington.
View Photo » -
AP Photo
Food and Drug Administration Commissioner-designate Margaret Hamburg testifies on Capitol Hill in Washington, Thursday, May 7, 2009, before the Senate Health, Education, Labor and Pension Committee hearing on her nomination.
View Photo » -
AP Photo
Food and Drug Administration Commissioner-designate Margaret Hamburg testifies on Capitol Hill in Washington, Thursday, May 7, 2009, before the Senate Health, Education, Labor and Pension Committee hearing on her nomination.
View Photo » -
AP Photo
Food and Drug Administration Commissioner-designate Margaret Hamburg testifies on Capitol Hill in Washington, Thursday, May 7, 2009, before the Senate Health, Education, Labor and Pension Committee hearing on her nomination.
View Photo » -
AP Photo
Food and Drug Administration Commissioner-designate Margaret Hamburg arrives for her confirmation hearing before the Senate Health, Education, Labor and Pension Committee hearing, Thursday, May 7, 2009, on Capitol Hill in Washington.
View Photo » -
AP Photo
Food and Drug Administration Commissioner-designate Margaret Hamburg smiles as she testifies on Capitol Hill in Washington, Thursday, May 7, 2009, during the Senate Health, Education, Labor and Pension Committee hearing on her nomination.
View Photo » -
AP Photo
Food and Drug Administration Commissioner-designate Margaret Hamburg testifies on Capitol Hill in Washington, Thursday, May 7, 2009, before the Senate Health, Education, Labor and Pension Committee hearing on her nomination.
View Photo » -
AP Photo
Food and Drug Administration Commissioner-designate Margaret Hamburg arrives for her confirmation hearing before the Senate Health, Education, Labor and Pension Committee hearing, Thursday, May 7, 2009, on Capitol Hill in Washington.
View Photo » -
AP Photo
Food and Drug Administration Commissioner-designate Margaret Hamburg testifies on Capitol Hill in Washington, Thursday, May 7, 2009, before the Senate Health, Education, Labor and Pension Committee hearing, on her nomination.
View Photo » -
AP Photo
FDA Commissioner Joshua Sharfstein, left, Agricultural Secretary Tom Vilsack, center, testifies on Capitol Hill in Washington, Thursday, May 7, 2009, before a Senate Appropriations subcommittee hearing on the swine flu.
View Photo » -
AP Photo
FDA Commissioner Joshua Sharfstein, left, accompanied by Agricultural Secretary Tom Vilsack, center, testifies on Capitol Hill in Washington, Thursday, May 7, 2009, before a Senate Appropriations subcommittee hearing on the swine flu.
View Photo » -
AP Photo
FDA Commissioner Joshua Sharfstein, left, Agricultural Secretary Tom Vilsack, center, testifies on Capitol Hill in Washington, Thursday, May 7, 2009, before a Senate Appropriations subcommittee hearing on the swine flu.
View Photo » -
AP Photo
FDA Commissioner Joshua Sharfstein testifies on Capitol Hill in Washington, Thursday, May 7, 2009, before a Senate Appropriations subcommittee hearing on the swine flu.
View Photo » -
Getty Images
WASHINGTON - APRIL 30: Acting Commissioner of Food and Drug Administration Joshua Sharfstein (L) speaks as Interim Deputy Director of Science and Public Health Program Rear Admiral Anne Schuchat of the Centers for Disease Control and Prevention looks on during a hearing before the Heal...
View Photo » -
Getty Images
WASHINGTON - APRIL 30: (L-R) Acting Commissioner of Food and Drug Administration Joshua Sharfstein, Interim Deputy Director of Science and Public Health Program Rear Admiral Anne Schuchat of the Centers for Disease Control and Prevention, and Assistant Health and Human Services Secreta...
View Photo » -
Getty Images
WASHINGTON - APRIL 30: Acting Commissioner of Food and Drug Administration Joshua Sharfstein speaks during a hearing before the Health Subcommittee of the House Committee on Energy and Commerce April 30, 2009 on Capitol Hill in Washington, DC.
View Photo » -
Getty Images
WASHINGTON - APRIL 30: (L-R) Acting Commissioner of Food and Drug Administration Joshua Sharfstein, Interim Deputy Director of Science and Public Health Program Rear Admiral Anne Schuchat of the Centers for Disease Control and Prevention, and Assistant Health and Human Services Secretar...
View Photo » -
AP Photo
FDA Commissioner Joshua Sharfstein, left, and Rear Admiral Anne Schuchat of the Center for Disease Control and Prevention arrive for a House Energy and Commerce Committee hearing on swine flu on Thursday, April 30, 2009 in Washington.
View Photo »
Getty Images
WASHINGTON - SEPTEMBER 29: Office of Compliance of the Food and Drug Administration's Center for Drug Evaluation and Research Division Director Michael Levy testifies before the Senate Judiciary Committee's Crime and Drugs Subcommittee during a hearing on 'Body Building Products and Hi...
View Photo »
